<code id='485332FCC2'></code><style id='485332FCC2'></style>
    • <acronym id='485332FCC2'></acronym>
      <center id='485332FCC2'><center id='485332FCC2'><tfoot id='485332FCC2'></tfoot></center><abbr id='485332FCC2'><dir id='485332FCC2'><tfoot id='485332FCC2'></tfoot><noframes id='485332FCC2'>

    • <optgroup id='485332FCC2'><strike id='485332FCC2'><sup id='485332FCC2'></sup></strike><code id='485332FCC2'></code></optgroup>
        1. <b id='485332FCC2'><label id='485332FCC2'><select id='485332FCC2'><dt id='485332FCC2'><span id='485332FCC2'></span></dt></select></label></b><u id='485332FCC2'></u>
          <i id='485332FCC2'><strike id='485332FCC2'><tt id='485332FCC2'><pre id='485332FCC2'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:3
          Good CEOs 2022
          Hyacinth Empinado/STAT

          It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

          This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

          advertisement

          What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Change Healthcare can notify patients about the breach, HHS says
          Change Healthcare can notify patients about the breach, HHS says

          KentNishimura/GettyImagesChangeHealthcarecannotifypatientswhosesensitivehealthinformationhasbeenexpo

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Stopping antidepressants leads to symptoms for 1 in 6 patients

          AdobeThemomentwhenapersonstopstakingtheirantidepressantisfraught.Notonlycanpatientsseetheirpsychiatr